Market Place
Sourcing Support
GeNeuro`s long COVID trial fails, triggering layoffs
28 Jun 2024 //
FIERCE BIOTECH
Data Monitoring Committee Recommends Continuing the Trial Evaluating Temelimab
11 Dec 2023 //
BUSINESSWIRE
GeNeuro and Verily Collaborate to Advance Long-COVID Research
19 Oct 2023 //
BUSINESSWIRE
GeNeuro Announces Recruitment of Patient in Centers in Trial Assessing Temelimab
16 Nov 2022 //
BUSINESSWIRE
Geneuro Receives CHF 6.7M in Funding to Develop Temelimab Against Long-COVID
13 Dec 2021 //
BUSINESSWIRE
GeNeuro announces agreement to assess W-ENV and long-Covid syndromes
27 Sep 2021 //
PHARMACEUTICAL-TECHNOLOGY
GeNeuro and Northwestern University Collaborate on HERV-W ENV in Long-haul COVID
24 Sep 2021 //
BUSINESSWIRE
How GeNeuro`s experimental MS drug might help treat COVID-19
15 Apr 2021 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.